C7 and metabolic dysfunction-associated steatotic liver disease: C7, which encodes a serum glycoprotein involved in forming a membrane attack complex, has been suggested as a potential biomarker for advanced fibrosis in NAFLD through proteomic screening [25] and is implicated in the disease's mechanism [26].